Merck & Company (MRK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,841,000 | 12,694,000 | 8,096,000 | 8,050,000 | 9,676,000 |
| Marketable Securities | 252,000 | 498,000 | N/A | N/A | 774,000 |
| Receivables | 10,349,000 | 9,450,000 | 9,230,000 | 6,803,000 | 6,778,000 |
| Inventories | 6,358,000 | 5,911,000 | 5,953,000 | 5,554,000 | 5,978,000 |
| Other current assets | 8,368,000 | 7,169,000 | 6,987,000 | 7,357,000 | 4,277,000 |
| TOTAL | $32,168,000 | $35,722,000 | $30,266,000 | $27,764,000 | $27,483,000 |
| Non-Current Assets | |||||
| PPE Net | 23,051,000 | 21,422,000 | 19,279,000 | 17,000,000 | 15,053,000 |
| Investments And Advances | 252,000 | 1,015,000 | 370,000 | 785,000 | 1,469,000 |
| Intangibles | 39,208,000 | 41,473,000 | 44,197,000 | 32,983,000 | 33,621,000 |
| Other Non-Current Assets | 11,996,000 | 9,528,000 | 11,582,000 | 13,056,000 | 6,771,000 |
| TOTAL | $74,507,000 | $73,438,000 | $75,428,000 | $63,824,000 | $56,914,000 |
| Total Assets | $106,675,000 | $109,160,000 | $105,694,000 | $91,588,000 | $84,397,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,922,000 | 4,264,000 | 4,609,000 | 4,327,000 | 3,738,000 |
| Accrued Expenses | 15,766,000 | 14,159,000 | 13,859,000 | 12,212,000 | 12,549,000 |
| TOTAL | $25,694,000 | $24,239,000 | $23,872,000 | $27,327,000 | $22,220,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 33,683,000 | 28,745,000 | 30,690,000 | 25,360,000 | 22,736,000 |
| aiOther Non-Current Liabilities | 8,780,000 | 8,316,000 | 9,421,000 | 12,488,000 | 12,054,000 |
| TOTAL | $43,346,000 | $38,863,000 | $43,565,000 | $38,857,000 | $36,176,000 |
| Total Liabilities | $69,040,000 | $63,102,000 | $67,437,000 | $66,184,000 | $58,396,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,532,644 | 2,538,593 | 2,527,734 | 2,530,316 | 2,536,269 |
| Common Shares | 1,788,000 | 1,788,000 | 1,788,000 | 1,788,000 | 1,788,000 |
| Retained earnings | 53,895,000 | 61,081,000 | 53,696,000 | 47,362,000 | 46,602,000 |
| Other shareholders' equity | -5,107,000 | -4,701,000 | -4,356,000 | -6,547,000 | -6,099,000 |
| TOTAL | $37,635,000 | $46,058,000 | $38,257,000 | $25,404,000 | $26,001,000 |
| Total Liabilities And Equity | $106,675,000 | $109,160,000 | $105,694,000 | $91,588,000 | $84,397,000 |